Karyopharm Therapeutics Inc. earnings per share and revenue

KPTI earnings per share for the last quarter are -0.26 USD whereas the estimation was -0.26 USD which accounts for 1.09% surprise. Company revenue for the same period amounts to 38.78 M USD despite the estimated figure of 37.92 M USD. Estimated earnings per share for the next quarter are -0.25 USD, and revenue is expected to reach 38.21 M USD. Also watch annual changes over time to get a bigger picture of KPTI earnings per share and revenue dynamics.